In November 2013, Brain & Behavior Research Foundation Scientific Council Member Alan F. Schatzberg, M.D., Kenneth T. Norris, Jr. Professor of Psychiatry and Behavioral Sciences at the Stanford University School of Medicine, joined a long list of distinguished scientists to receive the Anna-Monika Prize in Berlin, Germany. The Anna-Monika Foundation awards this prize bi-annually to clinical scientists dedicated to making major contributions to the understanding of the underlying neurobiological mechanisms of depression and to those who have advanced the pharmacological options for affective disorders.

Dr. Schatzberg has been an active investigator in the biology and psychopharmacology of depressive disorders and is a leading North American clinical and scientific psychiatrist. His research focuses on the interactions between the stress hormone (cortisol) system and dopamine metabolism, both at a basic science level and in clinical studies. Early in his career, Dr. Schatzberg explored norepinephrine systems in depression as a means of subtyping these disorders. His research has also provided major insights into the biological mechanisms that underlie the development of delusions in major depression and has opened innovative therapeutic strategies using glucocorticoid antagonists. He is an active investigator in the clinical psychopharmacology of nondelusional depression with a particular recent interest in chronic depression and in pharmacogenetics.

Dr. Schatzberg was also recognized with the Brain & Behavior Research Foundation Falcone Prize for Outstanding Achievement in Affective Disorders Research in 2005 (re-named the Colvin Prize for Outstanding Achievement in Mood Disorders Research in 2012).

Learn more about Dr. Schatzberg’s Anna-Monika Prize.